Evidence map›Paper›PMID 38021132›Full record

ArticleBiomedical optics express2023

Signal enhancement in spark-assisted laser-induced breakdown spectroscopy for discrimination of glioblastoma and oligodendroglioma lesions.

Parisa Mohammadimatin, Parviz Parvin, Amir Jafargholi, Amin Jahanbakhshi, Fatemeh Ahmadinouri, Alireza Tabibkhooei, Omid Heidari, Sareh Salarinejad

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Parisa MohammadimatinDepartment of Physics and Energy Engineering, Amirkabir University of Technology, P.O. Box 15875-4413, Tehran, Iran.
Parviz ParvinDepartment of Physics and Energy Engineering, Amirkabir University of Technology, P.O. Box 15875-4413, Tehran, Iran.
Amir JafargholiDepartment of Electronic and Electrical Engineering, University College London (UCL), United Kingdom.
Amin JahanbakhshiStem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, P.O. Box, 1997667665, Tehran, Iran.
Fatemeh AhmadinouriDepartment of Physics and Energy Engineering, Amirkabir University of Technology, P.O. Box 15875-4413, Tehran, Iran.ORCID https://orcid.org/0000-0001-7185-2479
Alireza TabibkhooeiSkull Base Research Center, Department of Neurosurgery, Iran University of Medical Sciences, P.O. Box, 1997667665, Tehran, Iran.
Omid HeidariDepartment of Physics and Energy Engineering, Amirkabir University of Technology, P.O. Box 15875-4413, Tehran, Iran.
Sareh SalarinejadShohada-e-Tajrish Hospital, Department of Pathology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, P.O. box 1985717443, Tehran, Iran.
Amirkabir University of Technology · IRIran University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, the discrimination of two types of lethal brain cancers, i.e., glioblastoma multiforme (GBM) and oligodendroglioma (OG) are investigated under the laser-induced breakdown spectroscopy (LIBS) and the electrical spark-assisted laser-induced breakdown spectroscopy (SA-LIBS) in order to discriminate the human brain glioma lesions against the infiltrated tissues. It is shown there are notable differences between the plasma emissions over the brain gliomas against those of infiltrated tissues. In fact, a notable enhancement appears in the characteristic emissions in favor of SA-LIBS against those of conventional LIB spectra. Moreover, the plasma properties such as temperature, electron density, and degree of ionization are probed through the data processing of the plasma emissions. The corresponding parameters, taken from SA-LIBS data, attest to be lucidly larger than those of LIBS up to one order of magnitude. In addition, the ionic species such as Mg II characteristic line at 279 nm and caII emission at 393 nm are notably enhanced in favor of SA-LIBS. In general, the experimental evidence verifies that SA-LIBS is beneficial in the discrimination and grading of GBM/OG neoplasia against healthy (infiltrate) tissues in the early stages.

Identifiers

PMID38021132
PMCPMC10659799
OpenAlexW4387140654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.